UiPath's Q1 2024 financial results were below analysts' expectations. The company reported a wider net loss than expected and slower revenue growth than anticipated.
Therefore it is an opportune time to accumulate #PATH UiPath Inc with a $21 target.
Therefore it is an opportune time to accumulate #PATH UiPath Inc with a $21 target.
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
